{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:49:55Z","timestamp":1790999395292,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS069566"],"award-info":[{"award-number":["NS069566"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS076896"],"award-info":[{"award-number":["NS076896"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12HL141956"],"award-info":[{"award-number":["K12HL141956"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.nbd.2020.104955","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T01:40:50Z","timestamp":1590284450000},"page":"104955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prion protein post-translational modifications modulate heparan sulfate binding and limit aggregate size in prion disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Julia A.","family":"Callender","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro M.","family":"Sevillano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Soldau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"Pizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Altmeppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7720-8817","authenticated-orcid":false,"given":"Markus","family":"Glatzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Esko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"Sigurdson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104955_bb0005","doi-asserted-by":"crossref","first-page":"43295","DOI":"10.1038\/srep43295","article-title":"Post-translational modifications in PrP expand the conformational diversity of prions in vivo","volume":"7","author":"Aguilar-Calvo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104955_bb0010","article-title":"Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions","author":"Aguilar-Calvo","year":"2019","journal-title":"Acta Neuropathol: Doi"},{"key":"10.1016\/j.nbd.2020.104955_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tcb.2015.08.007","article-title":"Cell biology of prions and Prionoids: a status report","volume":"26","author":"Aguzzi","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.nbd.2020.104955_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/bpa.12695","article-title":"Recent advances in the histo-molecular pathology of human prion disease","volume":"29","author":"Baiardi","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2020.104955_bb0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0003-2697(90)90405-X","article-title":"Permethylation and tandem mass spectrometry of oligosaccharides having free hexosamine: analysis of the glycoinositol phospholipid anchor glycan from the scrapie prion protein","volume":"191","author":"Baldwin","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2020.104955_bb0030","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1021\/bi2003907","article-title":"Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra","volume":"50","author":"Baron","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2020.104955_bb0035","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1073\/pnas.1232504100","article-title":"The interplay of glycosylation and disulfide formation influences fibrillization in a prion protein fragment","volume":"100","author":"Bosques","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104955_bb0040","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/oxfordjournals.bmb.a072649","article-title":"Scrapie strain variation and mutation","volume":"49","author":"Bruce","year":"1993","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.nbd.2020.104955_bb0045","series-title":"Slow Virus Infections of the Central Nervous System","first-page":"71","article-title":"Biological stability of different classes of scrapie agent. In slow virus infections of the central nervous system","author":"Bruce","year":"1979"},{"key":"10.1016\/j.nbd.2020.104955_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007662","article-title":"Full restoration of specific infectivity and strain properties from pure mammalian prion protein","volume":"15","author":"Burke","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.nbd.2020.104955_bb0055","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/jvi.65.12.6597-6603.1991","article-title":"N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state","volume":"65","author":"Caughey","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2020.104955_bb0060","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.1021\/bi00245a003","article-title":"Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy [published erratum appears in biochemistry 1991 Oct 29;30(43):10600]","volume":"30","author":"Caughey","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2020.104955_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/315331a0","article-title":"Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain","volume":"315","author":"Chesebro","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104955_bb0070","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1110837","article-title":"Anchorless prion protein results in infectious amyloid disease without clinical scrapie","volume":"308","author":"Chesebro","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.104955_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.1198461","article-title":"Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns","volume":"331","author":"Culyba","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.104955_bb0080","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1073\/pnas.0702662104","article-title":"Formation of native prions from minimal components in vitro","volume":"104","author":"Deleault","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104955_bb0085","first-page":"209","article-title":"Scrapie in sheep and goats","volume":"44","author":"Dickinson","year":"1976","journal-title":"Front. Biol."},{"key":"10.1016\/j.nbd.2020.104955_bb0090","series-title":"Unconventional Virus Diseases of the Central Nervous System","first-page":"446","article-title":"Further evidence that scrapie agent has an independent genome","author":"Dickinson","year":"1986"},{"key":"10.1016\/j.nbd.2020.104955_bb0095","doi-asserted-by":"crossref","first-page":"8380","DOI":"10.1021\/bi00447a017","article-title":"Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein","volume":"28","author":"Endo","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2020.104955_bb0100","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1021\/acs.jpclett.8b01570","article-title":"Design of Glyco-Linkers at multiple structural levels to modulate protein stability","volume":"9","author":"Feng","year":"2018","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.nbd.2020.104955_bb0105","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1073\/pnas.0308413101","article-title":"Cells release prions in association with exosomes","volume":"101","author":"Fevrier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104955_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1750-3639.1996.tb00796.x","article-title":"Prion Protein Amyloidosis","volume":"6","author":"Ghetti","year":"1996","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2020.104955_bb0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/smvy.1996.0024","article-title":"Prion protein hereditary amyloidosis - parenchymal and vascular","volume":"7","author":"Ghetti","year":"1996","journal-title":"Semin. Virol."},{"key":"10.1016\/j.nbd.2020.104955_bb0120","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1073\/pnas.93.2.744","article-title":"Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP","volume":"93","author":"Ghetti","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104955_bb0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-444-63945-5.00014-3","article-title":"Dominantly inherited prion protein cerebral amyloidoses - a modern view of Gerstmann-Straussler-Scheinker","volume":"153","author":"Ghetti","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2020.104955_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ilar\/ilv008","article-title":"The transmissible spongiform encephalopathies of livestock","volume":"56","author":"Greenlee","year":"2015","journal-title":"ILAR J."},{"key":"10.1016\/j.nbd.2020.104955_bb0135","series-title":"GLYCAM Web","author":"Group. W","year":"2020"},{"key":"10.1016\/j.nbd.2020.104955_bb0140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/neup.12379","article-title":"MM1-type sporadic Creutzfeldt-Jakob disease with 1-month total disease duration and early pathologic indicators","volume":"37","author":"Iwasaki","year":"2017","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2020.104955_bb0145","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","article-title":"Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases","volume":"21","author":"Jucker","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.104955_bb0150","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1111\/febs.14268","article-title":"Analyses of N-linked glycans of PrP(Sc) revealed predominantly 2,6-linked sialic acid residues","volume":"284","author":"Katorcha","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2020.104955_bb0155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033134","article-title":"Genetic PrP prion diseases","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.nbd.2020.104955_bb0160","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","article-title":"Molecular pathology of neurodegenerative diseases: principles and practice","volume":"72","author":"Kovacs","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.nbd.2020.104955_bb0165","doi-asserted-by":"crossref","first-page":"33674","DOI":"10.1074\/jbc.M804288200","article-title":"Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling","volume":"283","author":"Lawrence","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104955_bb0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nchembio.766","article-title":"Disease-specific non-reducing end carbohydrate biomarkers for mucopolysaccharidoses","volume":"8","author":"Lawrence","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2020.104955_bb0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-018-0248-6","article-title":"Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein","volume":"13","author":"Linsenmeier","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2020.104955_bb0180","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1074\/jbc.M114.556639","article-title":"Glycosylphosphatidylinositol anchoring directs the assembly of Sup35NM protein into non-fibrillar, membrane-bound aggregates","volume":"289","author":"Marshall","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104955_bb0185","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1006\/exnr.1997.6740","article-title":"Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice","volume":"149","author":"McBride","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.104955_bb0190","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tibs.2006.01.003","article-title":"N-linked oligosaccharides as outfitters for glycoprotein folding, form and function","volume":"31","author":"Mitra","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.nbd.2020.104955_bb0195","doi-asserted-by":"crossref","first-page":"12094","DOI":"10.1523\/JNEUROSCI.2417-10.2010","article-title":"Prion strain interactions are highly selective","volume":"30","author":"Nilsson","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.104955_bb0200","doi-asserted-by":"crossref","first-page":"30557","DOI":"10.1074\/jbc.M801877200","article-title":"Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease","volume":"283","author":"Notari","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104955_bb0205","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0092-8674(85)90333-2","article-title":"A cellular gene encodes scrapie PrP 27-30 protein","volume":"40","author":"Oesch","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.104955_bb0210","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1110\/ps.39201","article-title":"Strain-specified relative conformational stability of the scrapie prion protein","volume":"10","author":"Peretz","year":"2001","journal-title":"Protein Sci."},{"key":"10.1016\/j.nbd.2020.104955_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003872","article-title":"The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes","volume":"3","author":"Polymenidou","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2020.104955_bb0220","doi-asserted-by":"crossref","first-page":"14127","DOI":"10.1073\/pnas.1105880108","article-title":"Glycosylation of the enhanced aromatic sequon is similarly stabilizing in three distinct reverse turn contexts","volume":"108","author":"Price","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104955_bb0225","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/bip.22030","article-title":"N-glycosylation of enhanced aromatic sequons to increase glycoprotein stability","volume":"98","author":"Price","year":"2012","journal-title":"Biopolymers"},{"key":"10.1016\/j.nbd.2020.104955_bb0230","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.104955_bb0235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(90)90134-Z","article-title":"Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication","volume":"63","author":"Prusiner","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2020.104955_bb0240","series-title":"Techniques in Prion Research","first-page":"16","article-title":"Methods and tools in biosciences and medicine","author":"Raymond","year":"2004"},{"key":"10.1016\/j.nbd.2020.104955_bb0245","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/382180a0","article-title":"Nmr structure of the mouse prion protein domain Prp(121\u2212231)","volume":"382","author":"Riek","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104955_bb0250","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1073\/pnas.96.23.13044","article-title":"Glycosylation differences between the normal and pathogenic prion protein isoforms","volume":"96","author":"Rudd","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104955_bb0255","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1021\/bi002625f","article-title":"Prion glycoprotein: structure, dynamics, and roles for the sugars","volume":"40","author":"Rudd","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2020.104955_bb0260","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104955_bb0265","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2020.104955_bb0270","doi-asserted-by":"crossref","DOI":"10.1172\/JCI131564","article-title":"Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease","author":"Sevillano","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2020.104955_bb0275","doi-asserted-by":"crossref","first-page":"12303","DOI":"10.1128\/JVI.01120-06","article-title":"Strain fidelity of chronic wasting disease upon murine adaptation","volume":"80","author":"Sigurdson","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2020.104955_bb0280","article-title":"Ultrastructures and Strain Comparison of under-Glycosylated Scrapie Prion Fibrils","author":"Sim","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2020.104955_bb0285","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00687367","article-title":"Sulfated glycosaminoglycans in amyloid plaques of prion diseases","volume":"77","author":"Snow","year":"1989","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104955_bb0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00687367","article-title":"Sulfated glycosaminoglycans in amyloid plaques of prion diseases","volume":"77","author":"Snow","year":"1989","journal-title":"Acta Neuropathol Berl"},{"key":"10.1016\/j.nbd.2020.104955_bb0295","first-page":"601","article-title":"Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie","volume":"63","author":"Snow","year":"1990","journal-title":"Lab. Investig."},{"key":"10.1016\/j.nbd.2020.104955_bb0300","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1074\/jbc.M116.768010","article-title":"Sialylation controls prion fate in vivo","volume":"292","author":"Srivastava","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104955_bb0305","doi-asserted-by":"crossref","first-page":"11326","DOI":"10.1038\/s41598-018-29720-z","article-title":"Inflammatory response of microglia to prions is controlled by sialylation of PrP(Sc)","volume":"8","author":"Srivastava","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104955_bb0310","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0309-1651(91)90037-J","article-title":"Electrospray mass spectrometry of the glycosylinositol phospholipid of the scrapie prion protein","volume":"15","author":"Stahl","year":"1991","journal-title":"Cell Biol Int Rep"},{"key":"10.1016\/j.nbd.2020.104955_bb0315","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1073\/pnas.0712036105","article-title":"Mechanisms of prion protein assembly into amyloid","volume":"105","author":"Stohr","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104955_bb0320","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1371\/journal.pbio.0060100","article-title":"Host PrP glycosylation: a major factor determining the outcome of prion infection","volume":"6","author":"Tuzi","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.nbd.2020.104955_bb0325","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1146\/annurev-biochem-061516-045049","article-title":"Propagation of protein aggregation in neurodegenerative diseases","volume":"88","author":"Vaquer-Alicea","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.nbd.2020.104955_bb0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/glycob\/cww086","article-title":"Biological roles of glycans","volume":"27","author":"Varki","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.nbd.2020.104955_bb0335","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/path.2145","article-title":"Packaging of prions into exosomes is associated with a novel pathway of PrP processing","volume":"211","author":"Vella","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.nbd.2020.104955_bb0340","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","article-title":"Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay","volume":"358","author":"Wadsworth","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2020.104955_bb0345","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.1183748","article-title":"Generating a prion with bacterially expressed recombinant prion protein","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.104955_bb0350","doi-asserted-by":"crossref","first-page":"91r","DOI":"10.1093\/glycob\/cwj099","article-title":"Asparagine-linked protein glycosylation: from eukaryotic to prokaryotic systems","volume":"16","author":"Weerapana","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.nbd.2020.104955_bb0355","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/emboj\/20.3.377","article-title":"Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein","volume":"20","author":"Wong","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2020.104955_bb0360","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1242\/jcs.165472","article-title":"The multivesicular body is the major internal site of prion conversion","volume":"128","author":"Yim","year":"2015","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2020.104955_bb0365","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1074\/jbc.M113.531335","article-title":"Gerstmann-Straussler-Scheinker disease and \u201canchorless prion protein\u201d mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease","volume":"289","author":"Zanusso","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2020.104955_bb0370","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-444-63945-5.00009-X","article-title":"Sporadic Creutzfeldt-Jakob disease","volume":"153","author":"Zerr","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2020.104955_bb0375","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5","article-title":"Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants","volume":"48","author":"Zerr","year":"2000","journal-title":"Ann. Neurol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120302308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:19:52Z","timestamp":1760851192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120302308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":75,"alternative-id":["S0969996120302308"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104955","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prion protein post-translational modifications modulate heparan sulfate binding and limit aggregate size in prion disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104955"}}